Targeting aldosterone receptors in cerebrovascular disease

Sobey, Christopher (Primary Chief Investigator (PCI))
Arumugam, Thiruma (Chief Investigator (CI))
Drummond, Grant (Chief Investigator (CI))

Pharmacology

Project: Research

Status	Finished
Effective start/end date	1/01/14 → 31/12/17

Funding

National Health & Medical Research Council (NHMRC): AUD823,416.00

Related content

Research Output

IL-33 modulates inflammatory brain injury but exacerbates systemic immunosuppression following ischemic stroke

Research output: Contribution to journal › Article › Research › peer-review

Evidence of CCR2-independent transmigration of Ly6C^himonocytes into the brain after permanent cerebral ischemia in mice

Research output: Contribution to journal › Article › Research › peer-review

IL-37 increases in patients after ischemic stroke and protects from inflammatory brain injury, motor impairment and lung infection in mice

Research output: Contribution to journal › Article › Research › peer-review

Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress

Research output: Contribution to journal › Article › Research › peer-review

Effect of a selective mas receptor agonist in cerebral ischemia in vitro and in vivo

Research output: Contribution to journal › Article › Research › peer-review

Evidence that Ly6C(hi) monocytes are protective in acute ischemic stroke by promoting M2 macrophage polarization

Research output: Contribution to journal › Article › Research › peer-review

Brain immune cell composition and functional outcome after cerebral ischemia: comparison of two mouse strains

Research output: Contribution to journal › Article › Research › peer-review